Blue Owl-Backed Latigo Files for IPO, Adding to Biotech Pipeline
Latigo Biotherapeutics Inc. filed for an initial public offering, joining a growing list of biotechnology firms considering going public as soon as this quarter.
By Anthony Hughes · Bloomberg Markets
Latigo Biotherapeutics Inc. filed for an initial public offering, joining a growing list of biotechnology firms considering going public as soon as this quarter.